This Billion Operational Beat Reshapes AbbVie Thesis for Investors
AbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Discover which credit card has the best cash back offer available, ensuring you get the most value from your spending.
28,369 articlesAbbVie blew past first-quarter expectations with a $15.002 billion revenue print and raised full-year guidance, under...
Tilray’s stock has been a rollercoaster, but deciding whether to time dump your shares depends on your portfolio, ris...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Trilogy Metals has fallen hard this week, leaving investors asking whether the downturn is a short-lived pullback or ...
Adobe stock is staging a comeback after a brutal selloff, with stronger earnings and AI-driven growth fueling optimis...
Analysts lift Occidental targets to as high as $69, citing Permian efficiency and robust cash flow. Oil near $75 prov...
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Joby Aviation stock has been on a wild ride as headlines swirl around the company and the eVTOL market. This article ...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
PIMCO dismisses Trump’s NATO exit threats as noise, calling them a paper tiger. The note arrives as investors weigh t...
Strategic ambiguity around Bitcoin holdings prompted fresh market jitters as Michael Saylor hinted at selling a porti...
When space tech hype cools and SpaceX shares fall below, savvy investors weigh whether a dip is a buying signal or a ...